Preclinical Pharmacokinetics and Metabolism of BMS‐214778, a Novel Melatonin Receptor Agonist
- 1 April 2003
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 92 (4), 760-772
- https://doi.org/10.1002/jps.10348
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The Prevalence, Cost Implications, and Management of Sleep Disorders: An OverviewSleep and Breathing, 2002
- Human aging and melatonin. Clinical relevanceExperimental Gerontology, 2001
- Bioavailability of melatonin in humans after day-time administration of D7 melatoninBiopharmaceutics & Drug Disposition, 2000
- Sleep disorders in the elderly.Drugs & Aging, 1999
- Melatonin mediates two distinct responses in vascular smooth muscleEuropean Journal of Pharmacology, 1998
- Melatonin: a sleep-promoting hormone.Sleep, 1997
- Physiological Parameters in Laboratory Animals and HumansPharmaceutical Research, 1993
- Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- A physiological approach to hepatic drug clearanceClinical Pharmacology & Therapeutics, 1975
- Daily Rhythm in Human Urinary MelatoninScience, 1975